SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Semafore Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic Leukemia